Featured Jobs
|
Nova 401(k) Associates
|
|
EPIC RPS
|
|
July Business Services
|
|
DWC ERISA Consultants LLC
|
|
Distributions Processor - Qualified Retirement Plans Anchor 3(16) Fiduciary Solutions, LLC
|
|
The Pension Source
|
|
Defined Benefit Specialist II or III Nova 401(k) Associates
|
|
Retirement Combo Plan Administrator Heritage Pension Advisors, Inc.
|
|
Compensation Strategies Group, Ltd.
|
|
Merkley Retirement Consultants
|
|
BPAS
|
|
BPAS
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Press Releases by Date | Press Releases by Company Name
View More Press Releases by CalPERS [California Public Employees' Retirement System]
|
Press Release CalPERS Chief Investment Officer Yu (Ben) Meng Resigns |
|
Issued by CalPERS [California Public Employees' Retirement System] Aug. 6, 2020 |
|
SACRAMENTO, Calif. – CalPERS announced today that Chief Investment Officer Yu (Ben) Meng is resigning, effective August 5. Dan Bienvenue, deputy chief investment officer, will serve as interim chief investment officer. CalPERS will start an immediate search for a permanent successor. Meng has been CalPERS’ chief investment officer since January 2019. Under his leadership, CalPERS recently announced a fiscal year 2019-20 return of 4.7%, beating its benchmark of 4.3% during a time of extreme financial market volatility sparked by the coronavirus pandemic. “I deeply believe in the CalPERS mission of serving those who serve California,” Meng said. “I’m proud of the work we did to change the portfolio, build a skilled Investment Office, and set CalPERS on a strong path to achieve our return target. But at this time, it’s important for me to focus on my health and on my family and move on to the next chapter in my life.” |
View More Press Releases by CalPERS [California Public Employees' Retirement System]
|
Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink. |